Solubilization and characterization of high and low affinity pirenzepine binding sites from rat cerebral cortex. 1985

C P Berrie, and N J Birdsall, and E C Hulme, and M Keen, and J M Stockton

An apparently monomeric form of the digitonin-solubilized muscarinic acetylcholine receptor from the rat cerebral cortex retains a high affinity of 7 X 10(7) M-1 for pirenzepine. Muscarinic receptor binding sites in the rat cerebral cortex with a low affinity for pirenzepine are solubilized with relatively little change in affinity. The ability of pirenzepine to distinguish between subtypes of muscarinic binding site in the cerebral cortex is manifest in both the membrane-bound and soluble state.

UI MeSH Term Description Entries
D010095 Oxotremorine A non-hydrolyzed muscarinic agonist used as a research tool. Oxytremorine
D011813 Quinuclidinyl Benzilate A high-affinity muscarinic antagonist commonly used as a tool in animal and tissue studies. Benzilate, Quinuclidinyl
D011976 Receptors, Muscarinic One of the two major classes of cholinergic receptors. Muscarinic receptors were originally defined by their preference for MUSCARINE over NICOTINE. There are several subtypes (usually M1, M2, M3....) that are characterized by their cellular actions, pharmacology, and molecular biology. Muscarinic Acetylcholine Receptors,Muscarinic Receptors,Muscarinic Acetylcholine Receptor,Muscarinic Receptor,Acetylcholine Receptor, Muscarinic,Acetylcholine Receptors, Muscarinic,Receptor, Muscarinic,Receptor, Muscarinic Acetylcholine,Receptors, Muscarinic Acetylcholine
D002499 Centrifugation, Density Gradient Separation of particles according to density by employing a gradient of varying densities. At equilibrium each particle settles in the gradient at a point equal to its density. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Centrifugations, Density Gradient,Density Gradient Centrifugation,Density Gradient Centrifugations,Gradient Centrifugation, Density,Gradient Centrifugations, Density
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D004072 Digitonin A glycoside obtained from Digitalis purpurea; the aglycone is digitogenin which is bound to five sugars. Digitonin solubilizes lipids, especially in membranes and is used as a tool in cellular biochemistry, and reagent for precipitating cholesterol. It has no cardiac effects. Digitin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D012602 Scopolamine Derivatives Analogs or derivatives of scopolamine. Scopolamines,Derivatives, Scopolamine
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities

Related Publications

C P Berrie, and N J Birdsall, and E C Hulme, and M Keen, and J M Stockton
January 1994, Life sciences,
C P Berrie, and N J Birdsall, and E C Hulme, and M Keen, and J M Stockton
November 1985, European journal of biochemistry,
C P Berrie, and N J Birdsall, and E C Hulme, and M Keen, and J M Stockton
January 1986, Advances in experimental medicine and biology,
C P Berrie, and N J Birdsall, and E C Hulme, and M Keen, and J M Stockton
October 1985, The Journal of laboratory and clinical medicine,
C P Berrie, and N J Birdsall, and E C Hulme, and M Keen, and J M Stockton
June 1983, Proceedings of the National Academy of Sciences of the United States of America,
C P Berrie, and N J Birdsall, and E C Hulme, and M Keen, and J M Stockton
August 1984, Neuroscience letters,
C P Berrie, and N J Birdsall, and E C Hulme, and M Keen, and J M Stockton
January 1985, Journal de pharmacologie,
C P Berrie, and N J Birdsall, and E C Hulme, and M Keen, and J M Stockton
June 1991, Neuroscience letters,
C P Berrie, and N J Birdsall, and E C Hulme, and M Keen, and J M Stockton
June 1989, Journal of neurochemistry,
C P Berrie, and N J Birdsall, and E C Hulme, and M Keen, and J M Stockton
April 1992, The American journal of physiology,
Copied contents to your clipboard!